Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04773769 | Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas | unknown | N/A | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04768660 | Effects of Chewing Gum Against Postoperative Ileus | unknown | N/A | 10 | Assiut UniversityOTHER | 0 | Feb 24, 2021 | clinicaltrials |
| NCT04764084 | Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors | unknown | Phase 1 | 52 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT04663789 | Routine Staple Line Reinforcement for Minimally Invasive Distal Pancreatectomy(Double-Lock) | unknown | N/A | 124 | Peking Union Medical College HospitalOTHER | 1 | Feb 12, 2021 | clinicaltrials |
| NCT03374293 | Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer | unknown | Phase 2 | 21 | Shixiu WuOTHER | 1 | Feb 10, 2021 | clinicaltrials |
| NCT04524260 | The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical Patients | unknown | N/A | 80 | University of ZurichOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT03638193 | Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer | unknown | N/A | 10 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Feb 4, 2021 | clinicaltrials |
| NCT04737551 | Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study | unknown | — | 400 | Shanghai Zhongshan HospitalOTHER | 1 | Feb 4, 2021 | clinicaltrials |
| NCT03703063 | Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer | unknown | Phase 1 | 30 | Benaroya Research InstituteOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04723030 | The Transformation of Locally Advanced Pancreatic Cancer. | unknown | Phase 2 | 30 | Peking UniversityOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT03986294 | Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer(NAPAN) | unknown | Phase 2 | 122 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jan 15, 2021 | clinicaltrials |
| NCT04709445 | Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses | unknown | N/A | 100 | Charite University, Berlin, GermanyOTHER | 1 | Jan 14, 2021 | clinicaltrials |
| NCT04707118 | Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy | unknown | Phase 1 | 106 | Fudan UniversityOTHER | 1 | Jan 13, 2021 | clinicaltrials |
| NCT03525353 | Comparison Of Radiation Exposure To Patients During Endoscopic Retrograde Cholangiopancreatography (ERCP) Performed By Endoscopists Trained In Judicious Use Of Fluoroscopy With Those Without Formal Training | unknown | — | 1,000 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jan 12, 2021 | clinicaltrials |
| NCT04683497 | CE-IOUS for Patients With Pancreatic Cancer Undergoing Surgery: A Prospective, Proof-of-concept Trial | unknown | N/A | 50 | University of ThessalyOTHER | 0 | Jan 6, 2021 | clinicaltrials |
| NCT03215459 | Cardiopulmonary Exercise Testing: An Assessment of Patients Fitness for Palliative Chemotherapy for Pancreatic Cancer(CPET-Panc) | unknown | — | 100 | The Clatterbridge Cancer Centre NHS Foundation TrustOTHER | 0 | Jan 5, 2021 | clinicaltrials |
| NCT04425876 | A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer | unknown | Phase 1 | 74 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Dec 31, 2020 | clinicaltrials |
| NCT04687410 | Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs | unknown | N/A | 68 | Peter Vilmann MD, DSc, HC, FASGEOTHER | 1 | Dec 29, 2020 | clinicaltrials |
| NCT03989310 | An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 50 | Chinese PLA General HospitalOTHER | 1 | Dec 23, 2020 | clinicaltrials |
| NCT04668976 | A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma | unknown | Phase 2 | 100 | Benaroya Research InstituteOTHER | 1 | Dec 21, 2020 | clinicaltrials |
| NCT04662346 | Evaluation of Difficulty Score for Robotic Pancreatoduodenectomy | unknown | N/A | 1,000 | University of PisaOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT03475966 | Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program | unknown | N/A | 60 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Dec 8, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04605042 | Comparsion of WT and SNP Techniques of EUS-FNB in Pancreatic Solid Mass (WESP-PSM)(WESP-PSM) | unknown | N/A | 296 | Ruijin HospitalOTHER | 0 | Nov 27, 2020 | clinicaltrials |
| NCT04638868 | Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCs | unknown | N/A | 26 | Singapore General HospitalOTHER | 0 | Nov 23, 2020 | clinicaltrials |
| NCT04633382 | ENHANCED RECOVERY AFTER BILIARY TRACT SURGERY | unknown | N/A | 50 | Vitebsk State Medical UniversityOTHER | 0 | Nov 19, 2020 | clinicaltrials |
| NCT04636788 | Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer | unknown | N/A | 102 | Huazhong University of Science and TechnologyOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT04183478 | The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer | unknown | Phase 2 / Phase 3 | 600 | RenJi HospitalOTHER | 1 | Nov 12, 2020 | clinicaltrials |
| NCT02896803 | Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer(PanFLOX) | unknown | Phase 2 | 37 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Nov 10, 2020 | clinicaltrials |
| NCT04294589 | Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events(Flownet) | unknown | — | 250 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 10, 2020 | clinicaltrials |
| NCT04316507 | Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer Patients | unknown | N/A | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT04581876 | The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Oct 9, 2020 | clinicaltrials |
| NCT01703650 | Role of Perfusion CT in Pancreatic Cancer | unknown | — | 48 | Seoul National University HospitalOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03138213 | Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy | unknown | N/A | 656 | Tongji HospitalOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03302403 | Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors | unknown | N/A | 18 | Kang YUOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03383796 | Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma | unknown | N/A | 30 | Tongji HospitalOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT04571489 | A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 2 | 60 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | Oct 1, 2020 | clinicaltrials |
| NCT02717091 | Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer | unknown | Phase 2 | 50 | Nagoya UniversityOTHER | 0 | Sep 10, 2020 | clinicaltrials |
| NCT04520386 | OMT-111 for Terminal Stage Solid Tumors | unknown | Phase 2 | 78 | MetiMedi PharmaceuticalsINDUSTRY | 1 | Sep 9, 2020 | clinicaltrials |
| NCT04527679 | Cisplatin and Gemcitabine Chemotherapy and Lenvatinib for Patients With Unresectable Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 40 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 26, 2020 | clinicaltrials |
| NCT04523402 | Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis | unknown | Phase 2 | 100 | Eastern Hepatobiliary Surgery HospitalOTHER | 0 | Aug 21, 2020 | clinicaltrials |
| NCT04518800 | PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer | unknown | N/A | 20 | Chinese PLA General HospitalOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT04167007 | FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX(GEMFOX) | unknown | Phase 3 | 400 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT04517019 | Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy(OnkoFit II) | unknown | N/A | 201 | University Hospital TuebingenOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT04509687 | Training Endoscopists to Perform On-site Rapid Cytological Evaluation for EUS-FNA of Solid Pancreatic Lesions(EUS-FNA) | unknown | — | 60 | Changhai HospitalOTHER | 1 | Aug 12, 2020 | clinicaltrials |
| NCT04323917 | Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential | unknown | — | 850 | Istituto Clinico HumanitasOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT04506281 | PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors | unknown | Phase 2 | 128 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT04085055 | Fine Needle Biopsy of Solid Pancreatic Mass Lesions | unknown | N/A | 130 | AdventHealthOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT04498689 | Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer | unknown | Phase 2 | 117 | Fudan UniversityOTHER | 1 | Aug 4, 2020 | clinicaltrials |
| NCT02162914 | Regorafenib Versus Placebo to Treat Cholangiocarcinoma(REACHIN) | unknown | Phase 2 | 66 | Erasme University HospitalOTHER | 1 | Jul 31, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Feb 26, 2021source: clinicaltrials